Adverse effects of monoclonal antibodies in patients with multiple sclerosis: a real world experience

被引:0
|
作者
Baklan, M. [1 ]
Tuncel, R. [1 ]
Ekmekci, O. [1 ]
Yuceyar, N. [1 ]
机构
[1] Ege Univ Med Sch Hosp, Dept Neurol, Izmir, Turkey
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EP1586
引用
收藏
页码:881 / 881
页数:1
相关论文
共 50 条
  • [31] Monoclonal antibodies in pregnancy in patients with multiple sclerosis: an updated clinical guide
    Gklinos, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 529 - 529
  • [32] Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients
    Prockl, Victoria
    Nickel, Florian T.
    Utz, Kathrin S.
    Froehlich, Kilian
    Engelhorn, Tobias
    Hilz, Max-Josef
    Lee, De-Hyung
    Linker, Ralf A.
    Huhn, Konstantin
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 415
  • [33] Two-year real-world experience with ocrelizumab in the treatment of patients with multiple sclerosis
    Vollmer, B.
    Ijadi, N.
    Declusin, A.
    Nair, K.
    Sillau, S.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 595 - 596
  • [34] Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study
    Aguirre, Clara
    Alonso-Torres, Ana
    Aguera, Eduardo
    Garcia-Dominguez, Jose Manuel
    Montero-Escribano, Paloma
    Gonzalez-Quintanilla, Vicente
    Costa-Frossard, Lucienne
    Oreja-Guevara, Celia
    Reyes-Garrido, Virginia
    Caminero-Rodriguez, Ana Belen
    Riancho, Javier
    Sanchez, Octavio
    Forero, Lucia
    Perez-Parra, Fernando
    Ares-Luque, Adrian
    Tellez, Nieves
    Arzalluz-Luque, Joaquin
    Iglesias, Federico
    Casado-Ruiz, Virginia
    Castellano-Vicente, Alberto Jose
    Borrega, Laura
    Galan, Victoria
    de Antonio, Luis A. Rodriguez
    Romero, Carlos
    Garcia-Rodriguez, Raquel
    Cano-Orgaz, Antonio Tomas
    Sanchez-Menoyo, Jose Luis
    Perez-Ruiz, Domingo
    Gutierrez-Martin, Fuencisla
    Hernandez-Echevarria, Luis
    Meca-Lallana, Virginia
    CLINICAL DRUG INVESTIGATION, 2024, 44 (11) : 829 - 838
  • [35] Extended dosing of monoclonal antibodies in multiple sclerosis
    Kempen, Zoe L. E. van
    Toorop, Alyssa A.
    Sellebjerg, Finn
    Giovannoni, Gavin
    Killestein, Joep
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (13) : 2001 - 2009
  • [36] Getting specific: monoclonal antibodies in multiple sclerosis
    Lutterotti, Andreas
    Martin, Roland
    LANCET NEUROLOGY, 2008, 7 (06): : 538 - 547
  • [37] Personalised dosing of monoclonal antibodies in multiple sclerosis
    Van Kempen, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 10 - 10
  • [38] Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials
    Heliopoulos, Ioannis
    Patousi, Athanasia
    MEDICINAL CHEMISTRY, 2018, 14 (02) : 144 - 154
  • [39] Monoclonal antibodies in the therapy of multiple sclerosis An overview
    Rommer, P. S.
    Stueve, O.
    Goertsches, R.
    Mix, E.
    Zettl, U. K.
    JOURNAL OF NEUROLOGY, 2008, 255 (Suppl 6) : 28 - 35
  • [40] Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis
    Orthmann-Murphy, J. L.
    Calabresi, P. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (01) : 52 - 64